life scienc tool diagnost
price month
 close
forma ebitda million consensu million
cvet pf ebitda million miss million estim
weaker revenu underli profit lower
ebitda million million miss increment
invest slower expect synergi ramp ep
move vs prior lower ebitda factor line
pt move ebitda lower
revenu profit disappoint pf revenu fell estimate
normal org growth vs estimate excl agenc shift fx note
bp agenc headwind reflect associ sale shift
platform unquantifi america fell flat excl agenc
shift vs estimate reflect vca loss bp europ declin
organ also plan brexit headwind apac/em
ebitda margin fell bp plan bp gener million
cash cash reserv stand million leverag ratio
share declin sentiment admittedli low head
print share deterior latest disappoint
top-line profit experi well anoth ebitda guidanc cut
reflect pro forma ebitda growth y/i minimum far cri
initi dd growth aspir note underli market weak
disconnect anim health constitu expedit infrastructur
rose slightli plan share trade
ev/ebitda discount ah products/servic peer
view reflect technolog offer account
inher suppli chain unit risk contribut neutral view
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
one largest anim health distributor global
provid comprehens servic technolog platform
dedic support companion anim equin larg
blue sky scenario predic better
expect expans companion anim market support
innov product servic well greater
grey sky scenario assum vendor concentr
veterinari practic consolid compress margin also lower
expect revenu synergi captur veterinarian resist
wider spread accept vet first choic platform servic
price aug rate neutral target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
compani mention price
